CEO of F-star, a clinical-stage, NASDAQ-listed biopharmaceutical company focused on transforming the lives of patients with cancer.
Thirty years’ experience in the biotech and pharmaceutical sectors. Formerly CEO of Immunocore, successfully steering the company’s $320 million Series A fundraising.
Non-executive Chairman of Avacta plc; Chairman of Liverpool Health Partners; former Executive Chairman of MedCity. Also Board member of OSCHR (Office for Strategic Coordination of Health Research) and the National Genomics Board.
Honorary Visiting Professor of Molecular and Clinical Cancer Medicine at the University of Liverpool and Honorary Visiting Professor University of Pavia, Italy. PhD from the University of Liverpool and MBA from Henley Management College.